Chronic dexamethasone treatment potentiates insult to olfactory receptor cells produced by 3-methylindole

Brain Research

Volumn 847, Issue 2, 1999, Pages 240-246

  Kratskin, Igor L ^a   Kimura, Yasuyuki ^b   Hastings, Lloyd ^a   Doty, Richard L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

3 Methylindole; Anterograde labeling; Dexamethasone; Olfactory axon; Optical density; Rat

Indexed keywords

DEXAMETHASONE; SKATOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CELL DAMAGE; CELL LABELING; DEAFFERENTATION; ENZYME ACTIVITY; MALE; NONHUMAN; NOSE POLYP; OLFACTORY BULB; OLFACTORY RECEPTOR; OPTICAL DENSITY; PRIORITY JOURNAL; RAT;

ANIMALS; AXONAL TRANSPORT; DEXAMETHASONE; DRUG SYNERGISM; GLUCOCORTICOIDS; MALE; OLFACTORY BULB; OLFACTORY RECEPTOR NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SKATOLE; TOXINS, BIOLOGICAL;

EID: 0032703775     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02076-4     Document Type: Article

References (30)

1. Adams J.C. Heavy metal intensification of DAB-based HRP reaction product. J. Histochem. Cytochem. 29:1977;775.
2. Bradley B.J., Carlson J.R. Ultrastructural pulmonary changes induced by intravenous administered 3-methylindole in goats. Am. J. Pathol. 99:1980;551-560.
3. Burd G.D. Morphological study of the effects of intranasal zinc sulphate irrigation on the mouse olfactory epithelium and olfactory bulb. Microsc. Res. Tech. 24:1993;195-213.
4. Ding X., Coon M.J. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes. Biochemistry. 27:1988;8330-8337.
5. Gaskell B.A. Non-neoplastic changes in the olfactory epithelium - experimental studies. Environ. Health Perspect. 85:1990;275-289.
6. Hilberg O. Effect of terfenadine and budesnide on nasal symptoms, olfaction, and nasal airway following allergen challenge. Allergy. 50:1995;683-688.
7. Jafek B., Moran D., Eller P., Rowley C., Jafek T. Steroid-dependent anosmia. Arch. Otolaryngol. Head Neck Surg. 113:1987;547-549.
8. Kern R.C., Foster J.D., Pitovski D.Z. Glucocorticoid (type II) receptors in the olfactory mucosa of the guinea-pig: RU 28362. Chem. Senses. 22:1997;313-319.
9. Kimura Y., Miwa T., Furukawa M., Umeda R. Effects of topical application of steroids on olfactory disturbance in mice. Chem. Senses. 16:1991;297-302.
10. M.-M. Mesulam, Principles of horseradish peroxidase neurohistochemistry and their applications for tracing neural pathways - axonal transport, enzyme histochemistry and light microscopic analysis, in: M.-M. Mesulam (Ed.), Tracing Neural Connections with Horseradish Peroxidase, Wiley, Chichester, 1982, pp. 39-41.
11. A.E. Mott, Topical corticosteroid therapy for nasal polyposis, in: T.V. Getchell, R.L. Doty, L.M. Bartoshuk, J.B. Snow, Jr. (Eds.), Smell and Taste in Health and Disease, Raven Press, New York, 1991, pp. 553-572.
12. Owens J.G., James R.A., Moss O.R., Morgan K.T., Bowman J.R., Struve M.F., Dorman D.C. Design and evaluation of an olfactometer for the assessment of 3-methylindole-induced hyposmia. Fundam. Appl. Toxicol. 33:1996;60-70.
13. Peele D.B., Allison S.D., Bolon B., Prah J.D., Jensen K.F., Morgan K.T. Functional deficits produced by 3-methylindole-induced olfactory mucosal damage revealed by a simple olfactory learning task. Toxicol. Appl. Pharmacol. 107:1991;191-202.
14. Pereira T.M., Lechner M.C. Differential regulation of the cytochrome P450 3A1 gene transcription by dexamethasone in immature and adult rat liver. Eur. J. Biochem. 229:1995;171-177.
15. Reed C.J. Drug metabolism in the nasal cavity: relevance to toxicology. Drug Metab. Rev. 25:1993;173-205.
16. Sampol E., Mirrione A., Villard P.H., Piccerelle P., Scoma H., Berbis P., Durand A., Lacarelle B. Evidence for a tissue-specific induction of cutaneous CYP2E1 by dexamethasone. Biochem. Biophys. Res. Commun. 235:1997;557-561.
17. Scott A., Cain W.S., Clavet G. Topical corticosteroids can alleviate olfactory dysfunction. Chem. Senses. 13:1988;735.
18. Setzer A.K., Slotnick B.M. HRP transport from epithelium to olfactory bulb in rats treated with 3-methylindole. Chem. Senses. 17:1992;697.
19. Setzer A.K., Slotnick B.M. Olfaction in rats treated with 400 mg/kg 3-methylindole. Chem. Senses. 19:1994;552.
20. Setzer A.K., Slotnick B.M. Disruption of axonal transport from olfactory epithelium by 3-methylindole. Physiol. Behav. 65:1998;479-487.
21. Setzer A.K., Slotnick B.M. Odor detection in rats with 3-methylindole-induced reduction of sensory input. Physiol. Behav. 65:1998;489-496.
22. Shipley M.T. Transport of molecules from nose to brain: transneuronal anterograde and retrograde labelling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res. Bull. 15:1985;129-142.
23. Skiles G.L., Yost G.S. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole. Chem. Res. Toxicol. 9:1996;291-297.
24. Thornton-Manning J.R., Appleton M.L., Gonzalez F.J., Yost G.S. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methylene-indolenine formation and protein-binding. J. Pharmacol. Exp. Ther. 276:1996;21-29.
25. Turk M.A., Florey W., Henk W.G. Chemical modulation of 3-methylindole toxicosis in mice: effect on bronchiolar and olfactory mucosal injury. Vet. Pathol. 23:1986;563-570.
26. Turk M.A., Henk W.G., Florey W. 3-Methylindole-induced nasal mucosal damage in mice. Vet. Pathol. 24:1987;400-403.
27. Umeda R. The diagnosis and treatment of olfactory disturbance. J. Otolaryngol. Jpn. 84:1981;1362-1370.
28. Wang H., Lanza D.L., Yost G.S. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch. Biochem. Biophys. 349:1998;329-340.
29. Yost G.S. Mechanisms of 3-methylindole pneumotoxicity. Chem. Res. Toxicol. 2:1989;273-279.
30. Zupko K., Poria Y., Lancet D. Immunolocalization of cytochromes P-450olf1 and P-450olf2 in rat olfactory mucosa. Eur. J. Biochem. 196:1991;51-58.